UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

Nature reviews. Clinical oncology, 2016-05, Vol.13 (5), p.319-325

2016

Volltextzugriff (PDF)

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Journal of clinical oncology, 2015-03, Vol.33 (8), p.910-915

2015

Volltextzugriff (PDF)

Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1692-1698

2012

Volltextzugriff (PDF)

Pitfalls in Oncogeriatrics

Cancers, 2023-05, Vol.15 (11), p.2910

2023

Volltextzugriff (PDF)

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

PloS one, 2015-07, Vol.10 (7), p.e0133488-e0133488

2015

Volltextzugriff (PDF)

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

The lancet oncology, 2014-10, Vol.15 (11), p.1254-1262

2014

Volltextzugriff (PDF)

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1645-1651

2010

Volltextzugriff (PDF)

Angiogenesis Inhibitors in NSCLC

International journal of molecular sciences, 2017-09, Vol.18 (10), p.2021

2017

Volltextzugriff (PDF)

A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy

European journal of cardio-thoracic surgery, 2015-08, Vol.48 (2), p.196-200

2015

Volltextzugriff (PDF)

Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study

The lancet oncology, 2016-08, Vol.17 (8), p.1137-1146

2016

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions

The oncologist (Dayton, Ohio), 2006-07, Vol.11 (7), p.753-764

2006

Volltextzugriff (PDF)

The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis

Cancers, 2022-11, Vol.14 (21), p.5470

2022

Volltextzugriff (PDF)

Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions

The oncologist (Dayton, Ohio), 2009-04, Vol.14 (4), p.378-390

2009

Volltextzugriff (PDF)

Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1836-1843

2009

Volltextzugriff (PDF)

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.47-54

2020

Volltextzugriff (PDF)

Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy

BMJ open, 2019-12, Vol.9 (12), p.e033728-e033728

2019

Volltextzugriff (PDF)

1 – 25 von 1.472

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.301)
Mit Volltextzugriff
(1.225)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Medicinal Chemistry
(85)
Journal Of Clinical Oncology
(61)
International Journal Of Gynecological Cancer
(27)
Blood
(24)
Cancers
(24)
Bioorganic & Medicinal Chemistry
(23)
Tumori
(23)
Chemmedchem
(21)
The Lancet Oncology
(21)
Journal Of Cardiovascular Medicine
(20)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(26)

Menü

Weitere Dienste

Einstellungen

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

Pitfalls in Oncogeriatrics

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

Angiogenesis Inhibitors in NSCLC

A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy

Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial

Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial

The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study

Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions

Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial

Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review

Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system

Suchergebnisse filtern